Cytophage Expands Commercialization of Phage Products in Asian Poultry Market

Winnipeg, June 20, 2024. Cytophage Technologies Ltd. (TSXV:CYTO) (“Cytophage” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal health and human health, announces that it has signed of a Letter of Intent (LOI) with a leading Pan-Asian industrial agrifood company headquartered in Singapore.

The release as fetched from its publisher. cytophage.com ↗